4

PMH59 MODELLING THE ANTIDEPRESSANTS MARKET BEHAVIOUR AFTER PATENT EXPIRIES

Année:
2008
Langue:
english
Fichier:
PDF, 93 KB
english, 2008
12

VA8 HOW SHOULD HEALTH GAINS OF VACCINATION STRATEGIES BE DISCOUNTED?

Année:
2009
Langue:
english
Fichier:
PDF, 70 KB
english, 2009
20

PIN5 UNDERESTIMATION OF VARICELLA INCIDENCE IN THE NETHERLANDS

Année:
2009
Langue:
english
Fichier:
PDF, 80 KB
english, 2009
22

ID2: COST-EFFECTIVENESS ANALYSIS OF HEXAVALENT MENINGOCOCCAL B OUTER-MEMBRANE-VESICLE VACCINE

Année:
2000
Langue:
english
Fichier:
PDF, 70 KB
english, 2000
30

PMC14 DISCOUNTING HEALTH EFFECTS: A REVIEW OF THE SYSTEM

Année:
2010
Langue:
english
Fichier:
PDF, 78 KB
english, 2010
31

PMC9 A NEO-RICARDIAN APPROACH TOWARD DISCOUNTING

Année:
2010
Langue:
english
Fichier:
PDF, 76 KB
english, 2010
34

PHP34 ECONOMICS OF TRANSFUSION

Année:
2002
Langue:
english
Fichier:
PDF, 60 KB
english, 2002
37

IN5 ECONOMIC EVALUATION OF A LARGE-SCALE MENINGOCOCCAL C VACCINATION PROGRAM IN THE NETHERLANDS

Année:
2002
Langue:
english
Fichier:
PDF, 76 KB
english, 2002
38

IN4 DISCOUNTING HEALTH BENEFITS:A NOVEL APPROACH TO ENSURE PROPER VALUING OF VACCINATION STRATEGIES

Année:
2002
Langue:
english
Fichier:
PDF, 60 KB
english, 2002
44

PMD18 INDIRECT COSTS OF A LARGE-SCALE IMMUNIZATION PROGRAM—WHEN COSTS EXCEED SAVINGS

Année:
2003
Langue:
english
Fichier:
PDF, 65 KB
english, 2003
45

PHP20 SWITCH PATTERNS AROUND PATENT EXPIRY WITH ECONOMIC IMPLICATIONS FOR THE NETHERLANDS

Année:
2006
Langue:
english
Fichier:
PDF, 87 KB
english, 2006
46

PHM6 SOCIETAL COSTS OF ALLOGENEIC BLOOD TRANSFUSION IN THE NETHERLANDS

Année:
2006
Langue:
english
Fichier:
PDF, 66 KB
english, 2006
47

PGI7 COST-EFFECTIVENESS OF A POTENTIAL FUTURE HELICOBACTER PYLORI VACCINE IN THE NETHERLANDS

Année:
2006
Langue:
english
Fichier:
PDF, 73 KB
english, 2006